Treatment of advanced ovarian cancer: a randomised trial comparing adriamycin or 4' Epi-adriamycin in combination with cisplatin and cyclophosphamideBEZWODA, W. R.Medical and pediatric oncology. 1986, Vol 14, Num 1, pp 26-29, issn 0098-1532Article

The treatment of disseminated malignant melanoma with special reference to the role of interferons, vinca alkaloids and tamoxifenBEZWODA, W. R.Cancer treatment reviews. 1997, Vol 23, Num 1, pp 17-34, issn 0305-7372Article

High dose chemotherapy with haematopoietic rescue in breast cancerBEZWODA, W. R.Hematology and cell therapy (Print). 1999, Vol 41, Num 2, pp 58-65, issn 1269-3286Conference Paper

c-erb-B₂ expression and response to treatment in metastatic breast cancerBEZWODA, W. R.Medical oncology (Northwood). 2000, Vol 17, Num 1, pp 22-28, issn 1357-0560Article

Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens : comparison of aminoglutethimide plus hdyrocortisone with mexdroxyprogesterone acetate plus hydrocortisoneBEZWODA, W. R.British journal of urology (Print). 1990, Vol 66, Num 2, pp 196-201, issn 0007-1331, 6 p.Article

High-dose chemotherapy : therapeutic potential in the age of growth factor supportARIAD, S; BEZWODA, W. R.Israel journal of medical sciences. 1992, Vol 28, Num 6, pp 377-385, issn 0021-2180Conference Paper

Monocyte function after bone marrow transplantation: role of Ia⁺ monocytes in graft-versus-host diseaseBEZWODA, W. R; DANSY, R.Clinical transplantation. 1989, Vol 3, Num 5, pp 264-268, issn 0902-0063, 5 p.Article

Plasma lactoferrin content in neutropenic patients : effects of treatment with recombinant granulocyte-macrophage colony-stimulating factorBEZWODA, W. R; DAJEE, D.Molecular biotherapy. 1992, Vol 4, Num 2, pp 103-106, issn 0952-8172Article

Metastases of prostate cancer to breast: a case reportHESDORFFER, C; BEZWODA, W. R.SAMJ. South African medical journal. 1987, Vol 72, Num 7, pp 504-505, issn 0256-9574Article

In vitro maintenance of a new ovarian cancer cell line in protein-free media : a potential model for autonomous growth and tumor progressionGOLOMBICK, T; BEZWODA, W. R.European journal of cell biology. 1991, Vol 56, Num 2, pp 459-463, issn 0171-9335Article

Bisantrene in the treatment of relapsed acute non-lymphocyticBEZWODA, W. R; SEYMOUR, L.Bone marrow transplantation (Basingstoke). 1989, Vol 4, issn 0268-3369, p. 65, suppl. 3Conference Paper

Sequential α-interferon and tamoxifen : In vitro biologic effects of two growth modulatorsSEYMOUR, L; BEZWODA, W. R.International journal of oncology. 1997, Vol 10, Num 6, pp 1277-1282, issn 1019-6439Article

Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancerSEYMOUR, L; BEZWODA, W. R.Breast cancer research and treatment. 1994, Vol 32, Num 2, pp 229-233, issn 0167-6806Article

The use of mitoxantrone plus cyclophosphamide as first-line treatment of metastatic breast cancerBEZWODA, W. R; HESDORFFER, C.Cancer. 1986, Vol 58, Num 8, pp 1621-1624, issn 0008-543XArticle

Interferon plus tamoxifen treatment for advanced breast cancer : in vivo biologic effects of two growth modulatorsSEYMOUR, L; BEZWODA, W. R.British journal of cancer. 1993, Vol 68, Num 2, pp 352-356, issn 0007-0920Article

Isolation and characterisation of lactoferrin separated from human whey by adsorption chromatography using Cibacron Blue F3G-A linked affinity adsorbentBEZWODA, W. R; MANSOOR, N.Clinica chimica acta. 1986, Vol 157, Num 1, pp 89-93, issn 0009-8981Article

Comparison between immunocytochemical and polymerase chain reaction techniques for detection of oestrogen receptor and transforming growth factor β in breast cancerAMOILS, K. D; SEYMOUR, L; BEZWODA, W. R et al.British journal of cancer. 1996, Vol 73, Num 10, pp 1255-1259, issn 0007-0920Article

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer : a randomized trialBEZWODA, W. R; SEYMOUR, L; DANSEY, R. D et al.Journal of clinical oncology. 1995, Vol 13, Num 10, pp 2483-2489, issn 0732-183XArticle

A randomised trial of vindesine plus interferon-α2b compared with interferon-α2b or vindesine alone in the treatment of advanced malignant melanomaVOROBIOF, D. A; BEZWODA, W. R.European journal of cancer. Part A. 1994, Vol 30, Num 6, pp 797-800Article

Platelet-derived growth factor (PDGF) in plasma of breast cancer patients : correlation with stage and rate of progressionARIAD, S; SEYMOUR, L; BEZWODA, W. R et al.Breast cancer research and treatment. 1991, Vol 20, Num 1, pp 11-17, issn 0167-6806Article

TGF-β1 mRNA expression in clinical breast cancer and its relationship to ER mRNA expressionAMOILS, K. D; BEZWODA, W. R.Breast cancer research and treatment. 1997, Vol 42, Num 2, pp 95-101, issn 0167-6806Article

High-dose etoposide in treatment of metastatic breast cancerBEZWODA, W. R; SEYMOUR, L; ARIAD, S et al.Oncology. 1992, Vol 49, Num 2, pp 104-107, issn 0030-2414Article

Response to second-line hormone treatment for advanced breast cancer : predictive value of ploidy determinationSEYMOUR, L; BEZWODA, W. R; MEYER, K et al.Cancer. 1990, Vol 65, Num 12, pp 2720-2724, issn 0008-543X, 5 p.Article

Treatment of metastatic and recurrent cervix cancer with chemotherapy: a randomised trial comparing hydroxyura with cisdiamminedichloro-platinum plus methotrexateBEZWODA, W. R; NISSENBAUM, M; DERMAN, D. P et al.Medical and pediatric oncology. 1986, Vol 14, Num 1, pp 17-19, issn 0098-1532Article

Seizures after antiemetic treatment with high dose domperidone: report of four casesWEAVING, A; BEZWODA, W. R; DERMAN, D. P et al.British medical journal (1857). 1984, Vol 288, Num 6432, issn 0007-1447, 1728Article